These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29932603)
1. [Design, virtual screening, synthesis and anti-hepatitis B virus of oxime derivatives]. Cui XH; Tan J; Zhou M; Wei WX; Liu X; Wang LS Yao Xue Xue Bao; 2016 Oct; 51(10):1578-83. PubMed ID: 29932603 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Oxime Ethers as Hepatitis B Virus (HBV) Inhibitors by Docking, Screening and In Vitro Investigation. Tan J; Zhou M; Cui X; Wei Z; Wei W Molecules; 2018 Mar; 23(3):. PubMed ID: 29534537 [TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl ( Cui X; Zhou M; Tan J; Wei Z; Wei W; Luo P; Lin C Molecules; 2019 May; 24(11):. PubMed ID: 31151219 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents. Wei Z; Tan J; Cui X; Zhou M; Huang Y; Zang N; Chen Z; Wei W Molecules; 2020 Jul; 25(15):. PubMed ID: 32722086 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors. Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents. Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents. Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors. Zhang H; Lu G Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents. Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044 [TBL] [Abstract][Full Text] [Related]
10. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging. Dai JJ; Tao HM; Min QX; Zhu QH Phytomedicine; 2015 Jul; 22(7-8):724-9. PubMed ID: 26141758 [TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis B virus active constituents from Swertia chirayita. Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162 [TBL] [Abstract][Full Text] [Related]
12. Chemical constituents of Swertia mussotii and their anti-hepatitis B virus activity. Cao TW; Geng CA; Ma YB; Zhang XM; Zhou J; Tao YD; Chen JJ Fitoterapia; 2015 Apr; 102():15-22. PubMed ID: 25665940 [TBL] [Abstract][Full Text] [Related]
13. Schisanwilsonins A-G and related anti-HBV lignans from the fruits of Schisandra wilsoniana. Ma WH; Lu Y; Huang H; Zhou P; Chen DF Bioorg Med Chem Lett; 2009 Sep; 19(17):4958-62. PubMed ID: 19640714 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors. Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984 [TBL] [Abstract][Full Text] [Related]
15. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication. Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826 [TBL] [Abstract][Full Text] [Related]
16. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives. Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281 [TBL] [Abstract][Full Text] [Related]
17. Anti-hepatitis B virus activities of Geranium carolinianum L. extracts and identification of the active components. Li J; Huang H; Zhou W; Feng M; Zhou P Biol Pharm Bull; 2008 Apr; 31(4):743-7. PubMed ID: 18379075 [TBL] [Abstract][Full Text] [Related]
18. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors. Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L. Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives. Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]